Allworth Financial’s Processa Pharmaceuticals PCSA Stock Holding History

Allworth Financial’s Portfolio PCSA Stock Details PCSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3	Closed	-$117	–	4025
2024 Q3	$117	Hold	3	–	–	﹤0.01%	3652
2024 Q2	$139	Hold	3	–	–	﹤0.01%	3587
2024 Q1	$202	Hold	3	–	–	﹤0.01%	3447
2023 Q4	$569	Hold	3	–	–	﹤0.01%	3103
2023 Q3	$426	Hold	3	–	–	﹤0.01%	3081
2023 Q2	$846	Hold	3	–	–	﹤0.01%	2783
2023 Q1	$851	Hold	3	–	–	﹤0.01%	2729
2022 Q4	$1.87K	Hold	3	–	–	﹤0.01%	2265
2022 Q3	$4K	Hold	3	–	–	﹤0.01%	1955
2022 Q2	$5K	Hold	3	–	–	﹤0.01%	1761
2022 Q1	$5K	Hold	3	–	–	﹤0.01%	1639
2021 Q4	$8K	Hold	3	–	–	﹤0.01%	1472
2021 Q3	$15K	Hold	3	–	–	﹤0.01%	1125
2021 Q2	$14K	Buy	+3	New	+$11.6K	﹤0.01%	948

Other funds holding PCSA

HRT Financial New York $26B AUM 58.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Miracle Mile Advisors Los Angeles, California $7.28B AUM 16.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return